Leo H Bonati Selected Research

Patient Admission (Patient Admissions)

6/2022	Effect of admission time on provision of acute stroke treatment at stroke units and stroke centers-An analysis of the Swiss Stroke Registry.
1/2022	Occurrence of No-Harm Incidents and Adverse Events in Hospitalized Patients with Ischemic Stroke or TIA: A Cohort Study Using Trigger Tool Methodology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Leo H Bonati Research Topics

Disease

61	Stroke (Strokes) 12/2022 - 11/2006
37	Carotid Stenosis (Carotid Artery Stenosis) 01/2022 - 10/2008
22	Ischemic Stroke 12/2022 - 02/2014
16	Atrial Fibrillation 12/2022 - 01/2016
12	Pathologic Constriction (Stenosis) 06/2021 - 10/2009
7	Myocardial Infarction 12/2022 - 03/2010
5	Cranial Nerve Diseases (Cranial Nerve Disorders) 01/2022 - 10/2009
4	Hypertension (High Blood Pressure) 05/2022 - 01/2020
4	Hemorrhage 11/2021 - 09/2015
3	Atherosclerosis 01/2022 - 01/2012
3	Heart Failure 01/2021 - 01/2020
3	Cerebral Hemorrhage 01/2019 - 02/2014
2	Transient Ischemic Attack 01/2022 - 01/2020
2	Brain Infarction 09/2021 - 02/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2021 - 01/2021
2	Blood Vessel Dissection 01/2021 - 03/2018
2	Inflammation (Inflammations) 01/2021 - 01/2019
2	Diabetes Mellitus 01/2020 - 01/2020
2	Brain Ischemia (Cerebral Ischemia) 01/2019 - 01/2017
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 11/2016 - 03/2013
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 05/2022
1	Chronic Renal Insufficiency 01/2022
1	Dementia (Dementias) 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2020
1	Vascular Diseases (Vascular Disease) 01/2020
1	Hypotension (Low Blood Pressure) 01/2020
1	Neurologic Manifestations (Neurological Manifestations) 10/2019
1	Mitochondrial cytopathy 05/2019
1	MELAS Syndrome (Syndrome, MELAS) 05/2019
1	Coronary Disease (Coronary Heart Disease) 01/2019
1	Hemorrhagic Stroke 01/2017
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 05/2014
1	Leukoencephalopathies 02/2014
1	Infarction (Infarctions) 10/2008

Drug/Important Bio-Agent (IBA)

14	AnticoagulantsIBA 01/2022 - 09/2015
10	Vitamin K FDA Link 01/2022 - 09/2015
5	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2019
3	RivaroxabanIBA 01/2018 - 01/2017
2	Cystatin CIBA 01/2022 - 01/2020
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 11/2006
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2017
2	Retinaldehyde (Retinal)IBA 06/2021 - 06/2021
2	Glucose (Dextrose)FDA LinkGeneric 11/2019 - 03/2013
2	Phenobarbital (Luminal)FDA Link 01/2019 - 08/2017
1	omega-Chloroacetophenone (Mace)IBA 12/2022
1	Atrial Natriuretic Factor (ANF)IBA 12/2022
1	CreatinineIBA 01/2022
1	poly(dG-dA)n.poly(dC-dT)n (((GA)n))IBA 01/2022
1	SodiumIBA 01/2022
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 02/2021
1	docosapentaenoic acidIBA 02/2021
1	Eicosapentaenoic AcidIBA 02/2021
1	Docosahexaenoic AcidsIBA 02/2021
1	alpha-Linolenic Acid (Linolenic Acid)IBA 02/2021
1	AcenocoumarolIBA 01/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021
1	Heparin (Liquaemin)FDA LinkGeneric 01/2021
1	Phenprocoumon (Liquamar)FDA Link 01/2021
1	Warfarin (Coumadin)FDA LinkGeneric 01/2021
1	Lipoprotein(a)IBA 01/2021
1	Insulin-Like Growth Factor Binding ProteinsIBA 01/2021
1	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 01/2020
1	Anti-Arrhythmia AgentsIBA 01/2020
1	A-factor (Streptomyces)IBA 01/2020
1	Tumor Necrosis Factor Ligand Superfamily Member 14IBA 01/2020
1	Mitochondrial DNA (mtDNA)IBA 05/2019
1	2,6-dinitrotoluene (DNT)IBA 01/2017
1	Factor Xa (Coagulation Factor Xa)IBA 01/2017
1	N(4)-oleylcytosine arabinosideIBA 09/2015
1	ORALIT (ORS)IBA 05/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2014
1	C-Reactive ProteinIBA 03/2013
1	danaparoid (Orgaran)FDA Link 01/2012

Therapy/Procedure

35	Endarterectomy (Thromboendarterectomy) 01/2022 - 10/2008
25	Carotid Endarterectomy 06/2021 - 10/2009
15	Therapeutics 05/2022 - 10/2008
14	Stents 01/2021 - 10/2008
8	Aftercare (After-Treatment) 11/2019 - 10/2009
3	Thrombectomy 01/2022 - 08/2021
3	Secondary Prevention 01/2022 - 11/2016
2	Patient Admission (Patient Admissions) 06/2022 - 01/2022
1	Punctures 06/2022
1	General Anesthesia 01/2022
1	Local Anesthesia 12/2019
1	Contraindications 11/2019